← Back to Alzheimer's Drug Discovery Foundation Profile

Are there any recent news updates about Alzheimer's Drug Discovery Foundation?

Yes, recent news updates include the launch of a new phase of the Diagnostics Accelerator, the appointment of Isobel Coleman as Chief Executive Officer, the awarding of the 2026 Melvin R. Goodes Prize, and research updates on Semaglutide and Leqembi.

Source: Alzheimer's Drug Discovery Foundation

About Alzheimer's Drug Discovery Foundation:

The Alzheimer's Drug Discovery Foundation (ADDF) is a venture philanthropy organization dedicated to funding breakthrough research in academia and the biotech industry to find drugs for Alzheimer's disease. Founded in 1998 by Leonard A. and Ronald S. Lauder, the ADDF has awarded nearly $400 million to fund 792 Alzheimer's drug development, biomarker, and prevention programs in 21 countries.

Founded in 1998 by Leonard A. and Ronald S. Lauder
Awarded nearly $400 million in funding
Funded 792 Alzheimer's drug development programs
Operates in 21 countries

More Questions About Alzheimer's Drug Discovery Foundation

What is Alzheimer's Drug Discovery Foundation?: The Alzheimer's Drug Discovery Foundation (ADDF) is a venture philanthropy organization dedicated to funding breakthrough research in academia and the biotech industry to find drugs for Alzheimer's disease.
Where is Alzheimer's Drug Discovery Foundation located?: The Alzheimer's Drug Discovery Foundation is located in New York, USA.
When was Alzheimer's Drug Discovery Foundation founded?: The founding date of Alzheimer's Drug Discovery Foundation is not publicly available.
What type of investor is Alzheimer's Drug Discovery Foundation?: Alzheimer's Drug Discovery Foundation is a venture capital firm.
Does Alzheimer's Drug Discovery Foundation invest in Biotechnology?: Yes, Alzheimer's Drug Discovery Foundation invests in Biotechnology.
Does Alzheimer's Drug Discovery Foundation invest in Pharmaceuticals?: Yes, Alzheimer's Drug Discovery Foundation invests in Pharmaceuticals.

Verification Confidence: 90% | Source: accepts_cold_outreach | Entity: Alzheimer's Drug Discovery Foundation